KEYNOTE-564: pembrolizumab辅助治疗RCC的最新结果

{"title":"KEYNOTE-564: pembrolizumab辅助治疗RCC的最新结果","authors":"T. Powles, Robert van den Heuvel","doi":"10.55788/02614376","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":297105,"journal":{"name":"Medicom Conference Report EAU 2022","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"KEYNOTE-564: Updated results of adjuvant pembrolizumab in RCC\",\"authors\":\"T. Powles, Robert van den Heuvel\",\"doi\":\"10.55788/02614376\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":297105,\"journal\":{\"name\":\"Medicom Conference Report EAU 2022\",\"volume\":\"10 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicom Conference Report EAU 2022\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55788/02614376\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report EAU 2022","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/02614376","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}